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Qian Meng1, Xuguang Tao1,3,6, Xinliang Zhao1,3,6, Julia Zhong1,5, Weina Ju2, Yang Gu1, Edmund C Jenkins2,
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Abstract
Background: Preterm premature rupture of membranes (PPROM) is responsible for one third of all preterm births
(PTBs). We have recently demonstrated that long noncoding RNAs (lncRNAs) are differentially expressed in human
placentas derived from PPROM, PTB, premature rupture of the membranes (PROM), and full-term birth (FTB), and
determined the major biological pathways involved in PPROM.
Methods: Here, we further investigated the relationship of lncRNAs, which are differentially expressed in
spontaneous PTB (sPTB) and PPROM placentas and are found to overlap a coding locus, with the differential
expression of transcribed mRNAs at the same locus. Ten lncRNAs (five up-regulated and five down-regulated) and
the lncRNA-associated 10 mRNAs (six up- and four down-regulated), which were identified by microarray in
comparing PPROM vs. sPTB, were then validated by real-time quantitative PCR.
Results: A total of 62 (38 up- and 24 down-regulated) and 1,923 (790 up- and 1,133 down-regulated) lncRNAs were
identified from placentas of premature labor (sPTB + PPROM), as compared to those from full-term labor (FTB + PROM) and
from premature rupture of membranes (PPROM+ PROM), as compared to those from non-rupture of membranes
(sPTB + FTB), respectively. We found that a correlation existed between differentially expressed lncRNAs and their associated
mRNAs, which could be grouped into four categories based on the gene strand (sense or antisense) of lncRNA and its
paired transcript. These findings suggest that lncRNA regulates mRNA transcription through differential mechanisms.
Differential expression of the transcripts PPP2R5C, STAM, TACC2, EML4, PAM, PDE4B, STAM, PPP2R5C, PDE4B, and EGFR
indicated a co-expression among these mRNAs, which are involved in the ubiquitine-proteasome system (UPS), in addition
to signaling transduction and beta adrenergic signaling, suggesting that imbalanced regulation of UPS may present an
additional mechanism underlying the premature rupture of membrane in PPROM.
(Continued on next page)
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Conclusion: Differentially expressed lncRNAs that were identified from the human placentas of sPTB and PPROM may
regulate their associated mRNAs through differential mechanisms and connect the ubiquitin-proteasome system with
infection-inflammation pathways. Although the detailed mechanisms by which lncRNAs regulate their associated mRNAs in
sPTB and PPROM are yet to be clarified, our findings open a new approach to explore the pathogenesis of sPTB and
PPROM.
Keywords: Preterm birth (PTB), Preterm premature rupture of membrane (PPROM), Long non-coding RNA (lncRNA), mRNA,
Pathogenic mechanism
Background
Preterm premature rupture of membranes (PPROM),
which occurs in one-third of all preterm births (PTBs),
is one of the major causes of prematurity [1]. It accounts
for a disproportionate amount of perinatal morbidity
and mortality [2,3]. PPROM has been associated with
several pathologic processes [4,5]. In addition, preterm
contractions can lead to separation of the amnion and
choriodecidua, with an overall reduction in membrane
tensile strength, while cervical dilation can result in ex-
posure of the membranes to vaginal microorganisms
and reduce underlying tissue support [6]. The molecular
mechanisms, including epigenomic mechanisms, under-
lying sPTB and PPROM are not yet clearly understood.
Currently, high-throughput transcriptomic research
has indicated that eukaryotic genomes transcribe up to
90% of the genomic DNA [7]. Except for 1–2% of these
transcripts encoding for proteins, the vast majority
are transcribed as noncoding RNAs (ncRNAs) [7,8].
Although ncRNAs are defined by the lack of a protein-
coding sequence, they can play important roles in a var-
iety of biological processes [9,10]. ncRNAs are grouped
into two major categories according to their lengths: the
short noncoding RNAs, which include microRNAs
(miRNAs) as well as other non-coding transcripts of less
than 200 nucleotides (nts), and the more recently de-
scribed long noncoding RNAs (lncRNAs) that are longer
than 200 nt [11,12]. miRNAs, the most widely studied
class of short ncRNAs, mediate post-transcriptional gene
silencing by controlling the translation of mRNA into
protein [13,14] and are involved in regulating prolifera-
tion, differentiation, apoptosis, and development [15].
The disruption of expression of miRNAs has been found
in many human diseases including cancers, neurological
disorders, and cardiovascular disorders [15]. For ex-
ample, miR-15 and miR-16 are deregulated in B cell
chronic lymphocytic leukemia [16]; miR-206 deficiency
accelerates amyotrophic lateral sclerosis [17]; and miR-1,
which is involved in heart development, has been linked
with arrhythmias through down-regulating expression of
ion channel genes [18,19]. In addition, the disruption of
other classes of short ncRNAs, such as small nucleolar
RNAs (snoRNAs) and piwi-interacting RNAs (piRNAs),
can also lead to different human diseases [15]. For
example, the germline homozygous 2 bp (TT) deletion
of the snoRNA U50 is associated with prostate cancer
development [20], and overexpression of the piRNAs
piwiL1 and piwiL2 is involved in somatic tumors
[21-23]. Increasing evidence has revealed that lncRNAs
can function as regulators of protein-coding gene ex-
pression and exert a variety of intrinsic functions in
eukaryocytes [24]. In genomic contexts, lncRNAs can be
transcribed from enhancers, promoters, introns of genes,
pseudogenes, and antisense to genes [25]. They may in-
fluence almost every step in the life cycle of genes, and
they carry out their biological roles through several
different mechanisms, including regulating chromatin
states and nuclear compartments [26-28], affecting the
process of transcription [29-31], and mediating mRNA sta-
bility, splicing, and translation at the post-transcriptional
level [32-34]. Recently, the disruption of lncRNAs was also
found to be associated with different human diseases, as
short ncRNAs were [35]. ANRIL is the antisense lncRNA of
the INK4 locus, and its altered activity could result in
deregulated silencing of the INK4 locus, which contributes
to the initiation of several cancers [36-39]. The lncRNA
MALAT-1 is associated with early-stage non–small cell lung
cancer [40], which depends on its ability in regulating the al-
ternative splicing through interaction with nuclear phospho-
proteins [41,42]. In addition, the antisense lncRNA BACE1-
AS, which is encoded by the opposite strand of the gene
BACE1, can increase BACE1 mRNA stability and protein
abundance at the post-transcriptional level, as has been
shown to be true in Alzheimer’s disease [43]. Moreover,
based on the recent expression analyses, multiple lines of
evidence increasingly support the linkage of dysfunctions of
lncRNAs to other human diseases, including neurodegener-
ative and psychiatric diseases [44], cardiovascular disease
[45], and immune dysfunction and auto-immunity [30].
PPROM is a heterogeneous condition, although infec-
tion and inflammation are well documented as key etio-
logical factors [38,39,46]. Earlier, we have hypothesized
that the ncRNAs may play an epigenomic role in regu-
lating the pathogenic development of PPROM. To test
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this, we applied microchip technology and identified more
than a thousand placental lncRNAs. With these lncRNAs,
we delineated more than 20 potential pathogenic pathways
that are altered in PPROM [47]. Among these, we showed
that the pathways of infection and inflammatory response,
extra cellular matrix (ECM)-receptor interactions, apop-
tosis, actin cytoskeleton, and smooth muscle contraction
are the major pathogenic pathways involved in the devel-
opment of PPROM. Here, we further investigated whether
the differentially expressed lncRNAs, which were identi-
fied from placentas derived from PPROM, regulate related
mRNA transcription.
Methods
Ethics statement
The Ethics Committee of Lianyungang Maternal and Chil-
dren’s Hospital reviewed and approved the research project.
Written informed consent was obtained from the pregnant
women who participated in this study. All material and data
were previously coded and thus anonymous to the authors
of this study.
Placentas
A total of 40 placentas from age-matched pregnant women
(25–30 years old) were divided into four groups of deliveries
(10 placentas per group): sPTB, FTB, PPROM, and PROM,
labeled as group A, B, C, and D, respectively. sPTB is de-
fined as birth delivered at < 35 (= < 34+6) GW without
premature rupture of amniochorionic membrane (PROM),
FTB is defined as birth delivered at 39–40+6 GW with-
out PROM; PPROM is defined as birth delivered at < 35
(= < 34+6) GW with PROM; and PROM is defined as
birth delivered at 39–40+6 GW with premature rupture of
the amniochorionic membrane before labor, which is the
contraction of the uterus. Considering the epigenetic vari-
ation and high heterogeneity of PTB and PPROM, placen-
tas were selected from pregnancies by using the criteria
that there was no clinically recognized infection (no fever;
no increase of white blood cell counts; no positive finding
of amniotic fluid cultures; and no clinical intervention
with antibiotics, steroid, or tocolytics during the preg-
nancy). Immediately following delivery, the placentas were
flushed twice with 200 ml cold distilled water and dried
with clean paper towels, sliced with a sterile scalpel into
1×1 cm2 cubes at a site 2 cm from the edge of the pla-
centa, juxtaposed from the maternal side through the en-
tire fetal membrane, quickly frozen in liquid nitrogen for
30 minutes, and stored at −80°C until use. The entire pro-
cedure was to be completed within 30 minutes after the
placenta was delivered.
Microarray hybridization
The Arraystar Human LncRNA Array v2.0 (www.arrays-
tar.com) was employed in this study. This array covers
33,045 lncRNAs that were collected from the authoritative
data sources RefSeq, UCSC Knowngenes, and Ensembl.
RNA labeling and array hybridization were performed
according to the Agilent One-Color Microarray-Based
Gene Expression Analysis protocol (Agilent Technology,
Santa Clara, CA) with minor modifications. Briefly, mRNA
was purified from total RNA after removal of rRNA with
mRNA-ONLY™ Eukaryotic mRNA Isolation Kit (Epicentre,
Omaha, NE). Each sample was amplified and transcribed
into fluorescent cRNA along the entire length of the
transcripts without 3′ bias utilizing a random priming
method. The labeled cRNAs were purified by RNeasy
Mini Kit (Qiagen, Valencia, CA). The concentration and
specific activity of the labeled cRNAs (pmol Cy3/μg
cRNA) were measured by NanoDrop ND-1000. One μg
of each labeled cRNA was fragmented by adding 5 μl
10 × blocking agent and 1 μl of 25 × fragmentation buffer,
after which the mixture was heated at 60°C for 30 minutes,
and 25 μl 2 ×GE hybridization buffer was added to dilute
the labeled cRNA. Fifty μl of hybridization solution was dis-
pensed into the gasket slide and assembled to the lncRNA
expression microarray slide. The slides were incubated for
17 hours at 65°C in an Agilent Hybridization Oven. The hy-
bridized arrays were washed, fixed, and scanned by using
the Agilent DNA Microarray Scanner (Agilent Technology,
Santa Clara, CA). Agilent Feature Extraction software
(version 11.0.1.1) was used to analyze the acquired array
images. Quantile normalization and subsequent data pro-
cessing were performed using the GeneSpring GX v12.1
software package (Agilent Technologies, Santa Clara, CA).
After normalization of the raw data, lncRNAs and mRNAs
that have flags (“All Targets Value”) were chosen for further
data analysis. Differentially expressed lncRNAs and mRNAs
with statistical significance between the two groups were
identified through volcano plot filtering. Hierarchical clus-
tering was performed using the Agilent GeneSpring GX
software (Version 12.1). Both “GO analysis” and “Pathway
analysis” were performed in the standard enrichment com-
putation method. Results were also analyzed using the
genetic and molecular interaction software GeneMANIA
[48,49], an algorithm to indicate the co-relationship be-
tween these mRNA. The bio-functions and canonical path-
ways associated with our data were generated using the
option of core-analysis in Ingenuity Pathway Analysis (IPA)
(Ingenuity® Systems; http://www.ingenuity.com).
Quantitative real-time PCR analysis
Total RNA was extracted from placentas, and cDNA was
synthesized. The expression level of lncRNAs, as well as of
lncRNA-associated mRNAs, was determined by quantita-
tive real-time PCR (RT-qPCR). Primer sequences used in
qPCR were listed in Tables 1 and 2. qPCR reactions were
performed by the ABI7900 system (Applied Biosystems,
CA) and SYBR green dye PCR master mix (SuperArray,
Luo et al. BMC Pregnancy and Childbirth  (2015) 15:35 Page 3 of 17
CA). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
was used as an internal control, and lncRNAs’ or mRNAs’
values were normalized to GAPDH. Duplicated reactions
were analyzed for each quantitative assay. For each lncRNA
or mRNA, the result was finally reported as relative expres-
sion that was calculated relative to this control. All data were
given in terms of relative expression of mean ± S.E. (N = 10).
The data were subjected to one-way analysis of variance
(one-way ANOVA) followed by an unpaired, two-tailed
t-test. Differences were considered significant at P < 0.05
(labeled as “ * ” and extremely significant at P < 0.01 (labeled
as “ ** ”).
Results
Identification of differentially expressed lncRNAs in
comparisons of group AC (PTB & PPROM) vs. group BD
(FTB & PROM) and group CD (PPROM & PROM) vs. group
AB (PTB & FTB)
Differential expression was both up- and down-regulated. A
total of 62 (38 up- and 24 down-regulated) and 1,923 (790
up- and 1,133 down-regulated) lncRNAs were identified
from group AC placentas compared to group BD, and from
group CD compared to group AB, respectively (Figure 1A).
To visualize differential expression between two different
conditions, volcano plots (Figure 1B) were constructed by
using fold-change (magnitude of change) values ≥ 2.0 and p-
value < 0.05 as cut-offs, thus allowing visualization of the re-
lationship between fold-change and statistical significance,
which takes both magnitude of change and variability into
consideration. The vertical lines correspond to 2.0-fold up
and down, respectively, and the horizontal line represents
Table 1 Primers used for validation of lncRNA
LncRNA Primer
GAPDH 5′GAGTGGGTGTCGCTGTTGA3′
ENST00000437593 5′ GACCCATTCAAACTCTTTCACC3′
BC017431 5′ AAGCTGTCTGGTGCTGCTCTG3′
BF328678 5′ GGTAGAAGCGGATGAGTAGAAATAC3′
ENST00000423797 5′ GCAAGGAGAAGTGCCCAGAT3′
BX483760 5′ CCAGGCTGGTTTCAAACTCC3′
AA451649 5′ CTGAAGTGGAAGTTACAAGGAGGT3′
DN918055 5′ CTCCGCCATATTTGCCGTAC3′
AX747492 5′ CCACCGATGTCTGCCTATGTC 3′
BG258490 5′ CCAGTCTAGCCAACATAGCAAAC3′
BF667001 5′ GTTGTGGGTCGGTGTTTCC3′
Table 2 Primers used for quantitating mRNA
mRNA Primers Annealing (°C) Amplicom (bp)
GAPDH F:5′GGGAAACTGTGGCGTGAT3′ 60 299
R:5′GAGTGGGTGTCGCTGTTGA3′
ADAMTS15 F:5′TGTGAAAGTCTGTGAGGAGGTGT3′ 60 127
R:5′CAGGAAGTCGGTGATGATGG3′
AQPEP F:5′GGACACGGAATACATGGTGC3′ 60 137
R:5′CCTGGTCGGTGTAGACGTTG3′
EML4 F:5′TGAAGAGCCATGCAACGAGA3′ 60 95
R:5′AGCCAGGGTGTTAGGACGAG3′
NBPF10 F:5′ATCAGCTTCGCCCTTTACG3′ 60 82
R:5′TGACTCCCATCTGGAACACC3′
PAM F:5′CCAGACCCGTAGTTCCTATTGA3′ 60 96
R:5′ACATGCAGAAGTATGTATCGGACT3′
PDE4B F:5′CAGAAAGCAAGACCAGGAAGC3′ 60 185
R:5′GGATAAGTTCCCGAAACTTAGTGC3′
PPP2R5C F:5′TTCATCGAGGTCTCGGGTAT3′ 60 97
R:5′CTTGAAGTGACAGCAGTGGG3′
STAM F:5′TGGCAGTGACACCAAAGATAGAG3′ 60 141
R:5′TAGCAAGGGATTAGACAGACGAA3′
TACC2 F:5′GACACCTGTGATGAGTCCGTTG3′ 60 149
R:5′TTCTTGGCGGGCTTGTTTAG3′
TATDN1 F:5′TGAAAACTGAAGCTAATTTGGAA3′ 60 211
R:5′ GCAGGGTTCATTTCTGTCTTT3′
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Figure 1 (See legend on next page.)
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a p-value of < 0.05. Therefore, the red point in the plot
represents the differentially expressed lncRNAs with stat-
istical significance. LncRNAs’ p-value < 0.0001, so those
points were located in the axis Y = 4. Data of differentially
expressed lncRNAs, generated by the microarray, has been
deposited in Gene Expression Omnibus with an accession
number GSE 50879 (http://www.ncbi.nlm.nih.gov/geo/info/
linking.html).
Metabolic pathways involved in group AC (PTB & PPROM)
vs. group BD (FTB & PROM) and group CD (PPROM &
PROM) vs. group AB (PTB & FTB)
A functional analysis of mapping genes to KEGG (Kyoto
Encyclopedia of Genes and Genomes, www.genome.jp/
kegg/) pathways was performed with a p-value cut-off of
0.05. The p-value denotes the significance of the Pathway
correlated to the conditions. The lower the p-value, the
more significant is the Pathway. The up-regulated and
down-regulated pathways with the Top 10 scores in group
AC vs. group BD and group CD vs. group AB are shown in
Figure 2, respectively.
Quantitative real-time PCR validation of differentially
expressed lncRNAs and their associated mRNAs
In this study, 10 samples from each group were analyzed,
which gave a total of 40 samples. To address the tissue/cell
heterogeneity, we randomly selected five loci and per-
formed an intragroup analysis. Our results showed that
there was no significant difference (p > 0.05) among the 10
samples, but they did show intergroup differences that were
statistically significant.
Ten paired lncRNAs and their associated mRNAs
(PPP2R5C, STAM, TACC2, EML4, PAM, TATDN1, NBP
F10, ADAMTS15, AQPEP, and PDE4B) with different ex-
pression patterns were selected from microarray data
(Table 3). The selection was based on the following: 1) dif-
ferentially expressed lncRNAs are natural antisense, 2) the
sense strand of DNA has been transcribed into mRNA that
is differentially expressed, and 3) the function of the gene is
related to pathogenic pathway(s) that we have identified
earlier from PTB and PPROM [47] or from this study as
described above. RT-qPCR was used for validation of group
PPROM compared to sPTB, PROM, and FTB; group sPTB
compared to FTB and PROM; group PROM compared to
FTB; the group of preterm labor [PPROM+ sPTB] com-
pared to full-term labor [PROM + FTB]; and the group
of rupture of membrane [PPROM+ PROM] compared
to non-rupture of membrane [sPTB + FTB], respectively
(Figure 3). The results of qPCR are summarized in
Table 4. These comparisons revealed that, among 54 dif-
ferentially expressed loci by microarray, one lncRNA
(BC107431 in PPROM vs. sPTB) and seven mRNAs
(ADAMTS15 in PPROM vs. sPTB; TATDN1 in PPROM
vs. sPTB, PPROM vs. PROM, and [PPROM+ PROM] vs.
[sPTB + FTB]; AQPEP in PPROM vs. sPTB and sPTB vs.
FTB; and TACC2 in PPROM vs. sPTB) by qPCR did not
match the results of microarray, while 46 out of 54
(85.2%) were consistent with the results of microarray.
The target mRNAs of IncRNA interaction relationship
analysis by GeneMANIA
Ten differentially transcribed mRNAs regulated by IncRNA,
including PPP2R5C, STAM, TACC2, EML4, PAM, TAT
DN1, NBPF10, ADAMTS15, AQPEP, and PDE4B, were sub-
jected to GeneMANIA analysis. Six—PPP2R5C, STAM,
TACC2, EML4, PAM, and PDE4B—were found to be in a
functional network in terms of co-expression (Figures 4
and 5). The core pathway analysis of the 10 loci of
lncRNA-mRNA pairs showed that the top canonical path-
way of the mRNAs involved was cardiac β-adrenergic sig-
naling. Eight targeted mRNAs (ADAMTS15, EML4,
NBPF10, PAM, PDE4B, PPP2R5C, STAM, TACC2, and
TATDN1) and 27 ubiquitin protease pathway–associated
genes (www.ncbi.nlm.nih.gov/geo/info/linking.html, acces-
sion # GSE 50879) could be composed together to construct
a network (Figure 4). These genes can be subcategorized
into different families, including complex, enzyme, kinase,
peptidase, ion channel, phosphatase, and transporter, and
their top function and disease was DNA replication, recom-
bination, and repair; nucleic acid metabolism and small mol-
ecule biochemistry. The cellular locations of these molecules
can be mapped by IPA program, as shown in Figure 5, and
imply a possible signal transduction from extracellular to
nucleus.
Discussion
This current study is a continuing investigation to explore
the molecular mechanisms of lncRNA’s regulatory func-
tions in both PTB and PPROM, based on our findings that
lncRNAs are differentially expressed in the placentas of
PTB and PPROM [47]. Histologically, the placenta con-
tains both maternal (decidua) and fetal (chorionic villi and
chorioamnionic membranes) tissues. Instead of using fetal
(See figure on previous page.)
Figure 1 Heat Maps and Volcano plots of two comparisons. (A) Heat Maps: Differentially expressed lncRNAs for non-rupture of membrane
vs. rupture of membrane (AB vs. CD) and preterm labor vs. full-term labor (AC vs. BD) were hierarchically clustered. “Red” indicates high relative
expression, and “blue” indicates low relative expression. (B) Volcano Plots of two comparisons: X-axis is fold change (log 2) and Y-axis is p value
(−log 10). Up-regulated (X axis > 0) or down-regulated (X axis < 0) lncRNAs (red squares) were identified in about the same number when fold
change was set >2 folds [Log 2 (Fold change)] in PTB vs. PPROM.
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membranes, which are essential for investigating the mecha-
nisms directly related to the rupture of membrane, using the
placenta may help us identify the lncRNAs that are differen-
tially expressed in both maternal and fetal tissues and may
provide a broad source of information related to the patho-
physiological mechanisms underlying the premature con-
traction of the uterous, hemorrhage, and PROM, rather
than only rupture of membrane. In addition, using the pla-
centa as the study material may avoid the misidentifying of
lncRNAs that maybe expressed in maternal tissues but not
in fetal membranes. In our previous study, the lncRNAs
from PPROM placentas and the pathogenic pathways they
involved were identified based on microarray analysis [47].
However, the regulatory pattern between lncRNAs and their
associated mRNAs in PPROM is still unknown. In the
present study, the relationship between lncRNAs and their
associated mRNAs was detected, which may help us further
understand the molecular mechanism underlying PPROM.
PPROM, defined as rupture of the membranes before
37 weeks of gestation, contains two major pathogenic
Figure 2 Metabolic pathways identified from differentially expressed lncRNAs in PPROM. Four groups of pathways (each group has up- and
down-regulated) were characterized with KEGG functional analysis. Three p values, the EASE-score, Fisher-P value, and hypergeometric-P value, were
integrated for the analysis. The bar plot shows the top enrichment score [−log10(Pvalue)] value of the significant enrichment pathway. If there were
more than 10 pathways whose enrichment score is > 0.05, only the top 10 pathways are presented here. Three groups—AC vs. BD, up-regulation; CD
vs. AB, up-regulation; and CD vs. AB, down-regulation—are shown here, with no down-regulation for AC vs. BD because few pathways could be
identified by KEGG. The higher enrichment score indicates that more lncRNA molecules are involved in this pathway.
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Table 3 Correlation of differentially expressed lncRNAs with associated mRNAs detected by microarray
PPROM vs.
sPTB
PPROM vs.
PROM
PPROM vs. FTB sPTB vs. FTB PROM vs. FTB sPTB vs. PROM [PPROM + sPTB] vs.
[FTB + PROM]
[PPROM + PROM] vs.
[sPTB + FTB]
lncRNA mRNA lncRNA mRNA lncRNA mRNA lncRNA mRNA lncRNA mRNA lncRNA mRNA lncRNA mRNA lncRNA mRNA lncRNA mRNA
BF328678 ADAMTS15 Down Down
BG258490 PPP2R5C Down Down Down Down Down Down
AA451649 TATDN1 Down Up Up Down Down Up
BF667001 STAM Down Up Up Down Down Up Down Up Down Up
ENST00000423797 EML4 Down Up
AX747492 NBPF10 Up Up Down Down Up Up Up Up
BC107431 PAM Up Up
BX483760 AQPEP Up Up Down Up Up Up
DN918055 PDE4B Up Down Down Up Up Down Up Down Up Down
ENST00000437593 TACC2 Up Down
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factors, membrane rupture and preterm labor [50,51]. In
order to study these two factors individually, groups with
preterm labor or membrane rupture were analyzed by
microarray. Compared to the full-term group with or with-
out premature rupture of membrane (group BD), preterm
labor is now thought to be a syndrome initiated by multiple
mechanisms, including infection or inflammation, uteropla-
cental ischaemia or haemorrhage, uterine over-distension,
stress, and other immunologically mediated processes [52].
The up-regulated immune-related pathways in the preterm
labor group (group AC) placentas further indicated that im-
munoreaction was one of the important risk factors in pre-
term labor. On the other hand, differentially expressed
lncRNAs were identified from the premature membrane
rupture group (group CD) placentas compared to the con-
trol group (group AB). Among the top ten up-regulated
pathways, five were associated with microorganism infec-
tion, such as salmonella infection, influenza A, Chagas dis-
ease, measles, and legionellosis, and one (NOD-like receptor
signaling pathway) was associated with the pathogen recog-
nition process. One kind of etiologic factor linked to mem-
brane rupture was microorganism infection and maternal or
fetal host inflammatory response [5]. Infection-induced acti-
vation of membrane matrix-specific enzymes (matrix metal-
loproteinases, MMPs) has recently been shown to be
associated with excessive collagen turnover and membrane
weakening, leading to rupture [5]. The up-regulated
pathways about microorganism infection and pathogen rec-
ognition further indicated that genital infections and inflam-
matory reactions were important pathological factors in
membrane rupture. In addition, the up-regulated pathways
in the membrane rupture group also contained the p53 sig-
naling pathway, which was an important pathway leading to
apoptosis and has been demonstrated to play an integral
role in PPROM [4,53]. Up-regulated p53 signaling pathway
might explain that microorganism infection may initiate
membrane cell apoptosis through the p53 signaling pathway.
The top ten down-regulated pathways in the premature
membrane rupture group (group CD) were involved in
amino acid, actin cytoskeleton regulation, and other signal
transduction–related pathways. The down-regulation of
these pathways might suggest that the placenta cells of the
premature membrane rupture group have been in an apop-
tosis state and/or muscle contraction in a premature status,
assuming the lncRNA(s) played a suppressing function for
gene expression that resulted in increased transcription of
mRNA(s).
It is possible for the lncRNAs to be located in the same
strand or the antisense strand of their associated mRNA’s
locus. Our microarray data showed that of the 10 paired
lncRNAs and mRNAs studied, six pairs of locus TACC2,
NBPF10, PPP2R5C, PAM, AQPEP, and PDE4B were located
Figure 3 Validation of lncRNAs. RT-qPCR was applied to validate differentially expressed lncRNAs among eight pairs for comparison. Differential
expression was studied for lncRNAs and compared to that of mRNAs. Labels of lncRNA names in the left panels correlate to those of the mRNA names
in the right panels, e.g., ENST00000437593 of lncRNA correlates to mRNA TACC2, and BF667001 of lncRNA correlates to mRNA STAM. Significant levels
were indicated by *(p < 0.05) and **(p < 0.01).
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Table 4 Correlation of differential expression of lncRNAs with associated mRNAs detected by RT-qPCR
Seqname PPROM vs.
sPTB
PPROM vs.
PROM
PPROM vs. FTB sPTB vs. FTB PROM vs. FTB sPTB vs. PROM [PPROM + sPTB] vs.
[FTB + PROM]
[PPROM + PROM] vs.
[sPTB + FTB]
lncRNA mRNA lncRNA mRNA lncRNA mRNA lncRNA mRNA lncRNA mRNA lncRNA mRNA lncRNA mRNA lncRNA mRNA lncRNA mRNA
BF328678 ADAMTS15 down up up up up up down up down down down Up up up down down
BG258490 PPP2R5C down down up up up down down down down down down Up up up down down
AA451649 TATDN1 down down up up down up down up down down down Up down up down down
BF667001 STAM down up up down up down down up down up up Up up up down up
ENST00000423797 EML4 down up up down up down down up down up up Up up up down up
AX747492 NBPF10 up Up down down down down up up up up up Down down down up up
BC107431 PAM down Up up up up up down up down up up Up up up down up
BX483760 AQPEP up down down up down up up down up up up Down down down up down
DN918055 PDE4B up down down up up down up down up down up Up up down up down
ENST00000437593 TACC2 up Up down up up down up up up down up Up up up up up
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in the same strand (positive-strand), and the remaining four
(ADAMTS15, EML4, STAM, and TATDN1) were in the
antisense strands (Table 5). The differential expression pat-
tern of lncRNAs between microarray data and RT-qPCR
data among 27 comparisons (Table 3) showed 96% (26/27)
agreement. However, the differential expression of the tran-
scribed mRNA showed a lower rate (78%, 21/27) of agree-
ment (Tables 3 and 4), suggesting that lncRNA is more
stable than the coding mRNA. For example, both lncRNA
and mRNA of ADAMTS15 were down-regulated in micro-
array assays; however, the lncRNA was down- but the
mRNA was up-regulated in RT-qPCR. Nevertheless, Table 5
was constructed based on the qPCR results, in which we
may see four categories of possible mechanisms by which
lncRNA(s) regulate mRNA(s).
In the first category, lncRNAs and their associated
mRNAs were located in the same strand, and both had the
same expression pattern, which contains loci TACC2,
NBPF10, and PPP2R5C. Recently, researchers have found
that lncRNAs can compete for the miRNAs of mRNAs [25].
Because both lncRNA and mRNA are transcribed as the
positive strand (or leading strand, labeled as “+” in
Table 5), the possible mechanism of lncRNA regulating
mRNA is that lncRNAs may function to bind to miRNAs,
which protects mRNA from the miRNA targeting and
repressing. Consequently, the transcript of mRNA is up-
regulated, along with the up-regulation of lncRNA. TACC2,
which belongs to a conserved family of centrosome- and
microtubule-interacting proteins and encodes a protein that
is concentrated at centrosomes throughout the cell cycle
[54], represented an example of the phenomenon that when
lncRNA is up-regulated, the mRNA at the same locus would
be up-regulated, too. PPP2R5C represents another example
in which both lncRNA and mRNA were down-regulated.
PPP2R5C is one of the four major Ser/Thr phosphatases
[55]. It was reported that a number of mammalian pseudo-
genes and lncRNAs have miRNA-binding sites in their 3′-
UTRs and may therefore serve as “sponges” to sequester
miRNAs away from miRNA-targets [56,57]. Considering
that the lncRNAs and mRNAs of TACC2, NBPF10, and
PPP2R5C were all in the sense strands and had the same ex-
pression pattern in regulating mRNA transcript in PPROM,
Figure 4 Functional network of 10 mRNA obtained by GeneMANIA analysis. Color representations: purple co-expression, dark referred to
the target mRNAs. The core network of co-expression including PPP2R5C, STAM, TACC2, EML4, PAM, and PDE4B genes can be clearly seen.
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Figure 5 The network graph of 8 mRNAs from 10 mRNAs obtained by IPA pathway analysis. The red labels represent the target mRNAs
referred to as functionally related molecules that may be co-expressed.
Table 5 Regulation of lncRNAs on their associated mRNAs
PPROM vs. PTB Strand*
(lncRNA/mRNA)
lncRNA mRNA Gene name Possible regulation mechanism
lncRNA and mRNA with same expression
pattern and located in the same strand
+/+ ↑ ↑ TACC2 LncRNAs have miRNA-binding sites and
compete for the miRNAs of mRNA.
NBPF10
↓ ↓ PPP2R5C
lncRNA and mRNA with opposite
expression patterns and located in the
same strand
+/+ ↓ ↑ PAM The product of gene is a bifunctional
transcript, with one isoform as lncRNA and
another as mRNA.↑ ↓ AQPEP
PDE4B
lncRNA and mRNA with opposite
expression patterns and located in
opposite strands
−/+ ↓ ↑ ADAMTS15 LncRNA is the host to miRNAs which regulate
mRNA through RNAi.
EML4
STAM
ncRNA and mRNA with same expression
pattern and located in opposite strands
+/− ↓ ↓ TATDN1 LncRNA increases mRNA stability through
masking miRNA site of mRNA.
*: +, sense strand; −, antisense strand.
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the lncRNAs in the first category may regulate their associ-
ated mRNAs by competing for miRNA binding of mRNAs.
In the second category, lncRNAs and their associated
mRNAs were also located in the same strand, but they had
an opposite expression pattern, which contained loci of
PAM, AQPEP, and PDE4B. In this group, lncRNA and
mRNA might be transcribed bi-functionally. PDE4B is a
member of the cyclic AMP (cAMP)-specific phospho-
diesterase (PDE) family and encodes a protein that specific-
ally hydrolyzes cAMP [58]. Considering that cAMP is one
of the important second messengers regulating and mediat-
ing a number of cellular responses to extracellular signals,
such as hormones, light, and neurotransmitters [59-61], the
down-regulated PDE4B mRNA in the PPROM group might
imply that the cAMP-related signal transduction was in-
volved in the formation of PPROM. Another gene, AQPEP,
encoding a novel membrane-bound aminopeptidase termed
aminopeptidase Q, was expressed on extravillous tropho-
blast (EVT) during placentation [62,63]. It can degrade sev-
eral placenta-derived peptides including kisspeptin-10 [62],
which suppresses trophoblast as well as cancer migration
[64-66] and could also be involved in the regulation of EVT
migration. The down-regulation of AQPEP mRNA in the
PPROM group might indicate that the pathogenesis of
PPROM was associated with the placental lesion. In
addition, PAM, encoding a multifunctional protein with
catalytic activities to catalyze neuroendocrine peptides to ac-
tive alpha-amidated products [67,68], was up-regulated. Fur-
ther studies are needed to investigate the role of this gene in
PPROM. A recent interesting discovery about lncRNA indi-
cated that SRA is a bifunctional transcript, with one isoform
functioning as an ncRNA and another as an mRNA that is
translated into the protein SRAP [69,70], which may in turn
antagonize the function of its noncoding counterpart [71].
Since lncRNAs and their associated mRNAs located in the
same strand presented the opposite expression pattern,
which is considered as bidirectional lncRNA in the second
category, PAM, AQPEP, and PDE4B might possess similar
transcripts as SRA in PPROM.
In the third category, lncRNAs and their associated
mRNAs were located in different strands (lncRNAs in the
antisense strand, and mRNAs in the sense strand) and had
the opposite expression pattern, which contained genes of
ADAMTS15, STAM, and EML4. ADAMTS15 encodes a
member of the ADAMTS (a disintegrin and metalloprotein-
ase with thrombospondin motifs) protein family. Proteins in
the ADAMTS family share several distinct protein modules,
including a propeptide region, a metalloproteinase domain,
a disintegrin-like domain, and a thrombospondin type 1
motif [72,73]. Recently, researchers have found that degrad-
ation of extracellular matrix (ECM) by matrix metallopro-
teinases (MMPs) in fetal membrane plays significant roles in
membrane rupture in PPROM [5,74]. Moreover, several
other non-MMPs with a proteinase domain, such as serine
proteases, cysteine proteases, and ADAMTS family mem-
bers, can also break down amniochorion ECM substrates
[74]. The up-regulated mRNA expression of ADAMTS15
in the PPROM group might indicate that ADAMTS15
probably functioned as MMPs participating in the regula-
tion of collagenolysis and ECM degradation in PPROM
[5]. Another interesting gene, STAM, encodes a member
of the signal-transducing adaptor molecule family, which
mediates downstream signaling of the cytokine-cytokine
receptor interaction pathway [73]. Host inflammatory re-
sponses induced by different pro-inflammatory cytokines
(including IL-1β, IL-6, and TNF-α) were closely associated
with PPROM [5,75]. The up-regulated expression of
STAM mRNA might imply that STAM was probably in-
volved in PPROM through regulation of pro-inflammatory
cytokine-cytokine receptor interaction. To gain further
understanding of the regulation mechanism of STAM in
PPROM, KEGG analysis of this gene was processed. The
results revealed that STAM was involved in the JAK-STAT
signaling pathway (data not shown but available upon
request), which could be activated by IL-6 and cytokine re-
ceptor interaction. Moreover, depending on the connec-
tion with the MAPK or PI3K-Akt signaling pathways,
STAM could participate in the regulation of apoptosis.
Apoptosis has been demonstrated to play an integral role
in PPROM, and IL-6 also has been proved to promote
MMP activation or apoptosis of fetal membranes in
PPROM. Therefore, STAM might regulate apoptosis of
fetal membranes in PPROM by mediating downstream
signaling of the IL-6 and cytokine receptor interaction
pathway. The last gene in this category was EML4, which
encodes a novel microtubule-associated protein belonging
to the conserved family of EMAP-like proteins. EML4 has
been demonstrated to be essential for microtubule forma-
tion [76]. Up-regulated expression of EML4 mRNA might
imply that microtubule formation of the cytoskeleton in
fetal membranes possibly was abnormal in PPROM. Be-
cause lncRNAs and mRNAs of ADAMTS15, STAM, and
EML4 were located in opposite strands, lncRNAs in the
third category could be complementary to their associated
mRNAs. Although no evidence to date has demonstrated
that lncRNAs can directly down-regulate their complemen-
tary mRNA through the RNAi-like pathway as miRNAs,
the opposite expression pattern of antisense lncRNAs
and sense mRNAs in this category could be explained
by another new finding that lncRNAs could be the host
genes for small RNAs [77]. For example, lncRNA H19 is
host to miR-675 [78], and the imprinted Gtl2, anti-Rtl1,
and Mirg RNAs are hosts to almost 50 miRNAs and 40
snoRNAs [79]. These lncRNAs could yield Dicer-
dependent small RNAs and repress their complemen-
tary mRNAs through an RNAi-related pathway [77],
which might be the mechanism whereby lncRNAs regu-
late mRNAs in this category.
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In the fourth category, lncRNAs and their associated
mRNAs were also located in opposite strands (lncRNAs in
the antisense strand, and mRNAs in the sense strand), but
they had the same expression pattern, which contained only
one gene, TATDN1. TATDN1 encodes a protein known as
a DNase domain-containing protein, which plays an import-
ant role in chromosomal segregation and cell cycle progres-
sion [80]. TATDN1 is a conserved nuclease in both
prokaryotes and eukaryotes and has been found to play a
role in apoptotic DNA fragmentation in yeast and C. elegans
[81,82]. Although it is unclear whether TATDN1 in verte-
brates also functions in apoptotic DNA fragmentation, the
down-regulation of TATDN1 mRNA in the PPROM group
at least suggested that TATDN1 might be associated with
PPROM by regulating DNA fragmentation. A recent study
about Alzheimer’s disease found that the antisense transcript
of the Alzheimer-associated b-secretase-1 (BACE), known
as BACEAS, increases BACE mRNA stability [43], most
likely by masking the binding sites for miR-485-5p [83],
which suggested that lncRNAs could interfere with miRNA-
mediated mRNA destabilization. Because lncRNAs and
mRNA of TATDN1 were located in the opposite strand,
and both were down-regulated in the PPROM group,
lncRNAs of TATDN1 might regulate its mRNA as BACEAS
by masking the miRNA-binding sites of its mRNA in
PPROM.
Although the 10 lncRNA-targeting mRNAs may be regu-
lated by lncRNA with different mechanisms, six of them—
PPP2R5C, STAM, TACC2, EML4, PAM, and PDE4B—were
found to be directly co-expressed [84-87] in one network by
GeneMANIA analysis, which indicated that their expression
levels are similar across conditions. Three of these mRNAs,
STAM, PPP2R5C, and PDE4B, and another co-expressed
gene, SMAD6, were found to be involved in the signal trans-
duction pathway (REACTOME REACT_111102.4) [88].
Signal transduction is a process in which extracellular sig-
nals elicit changes in cell state and activity. Depending on
the cellular context, the signaling transduction pathway may
impact cellular proliferation, differentiation, and survival. In
these signaling pathways, PDE4B and PPP2R5C are involved
in cardiac β-adrenergic signaling, which regulates the con-
traction of muscles. The earlier occurrence of uterine con-
traction was one of the main factors for PPROM. Therefore,
the β-adrenergic signaling in uterine smooth muscles cells
may be an important signaling pathway involved in PPROM.
Further investigations should be pursued to explore how the
mRNAs involved in this pathway are regulated by lncRNAs.
In addition to smooth muscle contraction, the ubiqui-
tin C (UBC) network constructed by the eight lncRNA-
targeted transcripts is shown in Figures 4 and 5. At the
protein level, these targeted transcripts were found to
interact with each other [89,90]. UBC is a polyubiquitin
precursor. Conjugation of ubiquitin monomers or poly-
mers can lead to various effects within a cell, depending
on the residues to which ubiquitin is conjugated. Ubiquiti-
nation has been associated with protein degradation, DNA
repair, cell cycle regulation, kinase modification, endocyto-
sis, and regulation of other cell signaling pathways [91].
Protein degradation was one of the pathophysiological
changes for PPROM. Although MMP was one of the clari-
fied factors associated with PPROM, the mechanism of
PPROM was still unclear. Protein degradation through the
ubiquitin-proteasome system (UPS) is the major pathway
of non-lysosomal proteolysis of intracellular proteins and
played a modulation role in the immune and inflamma-
tory responses. Our analysis provided a possible explan-
ation for the multiple pathways involved in PPROM under
the regulation of UPS. In our analysis, STAM has two
ubiquitin-binding domains, Vps27/Hrs/Stam (VHS) and
ubiquitin-interacting motif (UIM), at its N-terminus, and
its function was as a signal-transducing adaptor, which
mediates downstream signaling of the cytokine-cytokine
receptor interaction pathway. PPP2R5C is involved in mul-
tiple pathways, and its dephosphorization may also play a
central role in regulation of target proteins’ degradation via
the UPS. Our finding that transcription of mRNA of STAM
may be regulated by lncRNA opens a new approach to study
the pathogenesis of sPTB and PPROM through the connec-
tion between UPS and infection-inflammation pathways.
Conclusions
In conclusion, differentially expressed lncRNAs identified
from the human placentas of PPROM might regulate their
associated mRNAs through different mechanisms, as dis-
cussed above. The possible regulatory pattern between these
lncRNAs and their associated mRNAs in PTB and PPROM
might represent the potential molecular mechanism under-
lying PTB and PPROM. Although the detailed mechanisms
through which lncRNAs regulate their associated mRNAs in
sPTB and PPROM must be further clarified, our findings
have identified a new way to explore the pathogenesis of
sPTB and PPROM in the near future.
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